GERM ETFMG Treatments Testing and Adv ETF
Prime Treatm, Testing and Adv TR USD

NAV as of 16-May-2022

22.6757

4 Week: 20.89 - 25.80

52 Week: 20.89 - 45.54

Latest Closing Price

23.51

Premium / Discount

-0.08

Expense Ratio

0.68%

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Prime Treatments, Testing and Advancements Index. The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.

Main Fund Characteristics

Fund Manager:
ETFMG
Asset Under Management:
28,430,807
Launch Date:
16/06/2020
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
84
Trading Currency:
USD
Style:
Mid Blend
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-34.022.51-13.54
1 Day3.730.000.00
1 Week5.9510.290.58
1 Month-10.8414.34-0.76
3 Months-14.2620.19-0.71
6 Months-36.6027.99-1.31
1 Year-35.7134.70-1.03
2 Years0.000.000.00
3 Years0.000.000.00
5 Years0.000.000.00
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.000014.9502
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.00000.00000.000032.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
N.A

Portfolio Data

Total Number of Holdings: 84

Number of Bond Holdings: 0

Number of Equity Holdings: 82

Total Market Value: 28,430,807

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Laboratory Corp of America Holdings6.283913,86603,472,324

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant8.39
Large19.57
Medium28.02
Small13.30
Micro21.71

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

8.2947

Price/Book*

1.6065

Price/Sales*

1.2294

Price/Cash Flow*

4.1988

Dividend Yield*

0.5363

Growth Measures

Long-Term Earnings

13.1899

Historical Earnings

54.7643

Sales Growth

38.5055

Cash-Flow Growth

102.1230

Book-Value Growth

1.4083

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*1.60
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
1 to 3 Years3.26
3 to 5 Years0.01
5 to 7 Years0.00
7 to 10 Years0.00
10 to 15 Years0.00
15 to 20 Years0.00
20 to 30 Years0.00
Over 30 Years0.00
1 to 7 Days0.00
8 to 30 Days0.00
31 to 90 Days0.00
91 to 182 Days0.09
183 to 364 Days0.82

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.